Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Controlled Cold Exposure Combined With PD-1/PD-L1 Immunotherapy in Solid Tumors
NCT07538479Phase 1Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in solid tumor, sponsored by West China Hospital of Sichuan University. Primary endpoints: Incidence of Adverse Events, Serious Adverse Events, and Safety-Related Treatment Modifications and Completion Rate and Adherence to Controlled Cold Exposure. Started Apr 2026; status: recruiting.
02
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07538479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07538479.